Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Money the company can't afford to waste. Maybe the person on the BOD who sanctioned that ought to take a pay cut! ( Just seen a pig fly by!)
Just to let you know — we've received your order #149353, and it is now being processed: 07/10/2020
What a waste of time and money that exercise was then..........
Should have said this was from trustpilot 6 days ago.
"We are trialling this new form of packaging at the moment, and we are sorry you have found the lid a little difficult to open. We would suggest please that you try gently squeezing the front and back of the bottle near the lid when you try to remove the lid - this breaks the air seal and makes the lid much easier to remove.
We appreciate the very helpful feedback we have had from a number of customers on this subject, and would confirm that we now expect to reintroduce blister packs with individually sealed capsules in the next few months."
I thought that 10 years ago!
LOL!!!
Can't say I prefer the new packaging to the previous blister packs. Wasteful double wrapping and almost impossible to get the lid off the inner carton without using a kitchen implement of some sort. It also make judging the amount of capsules left a bit harder.
I wonder what bright spark came up with that idea bearing in mind most Companies are moving towards LESS packaging! What was wrong with blister packs?
Assume IF will now be sending an Email to all the Provexis FF+O customers giving them the same info and asking them to 'PASS IT ON'....
lol !
https://www.facebook.com/fruitflowplus/posts/2426630544304603?__cft__[0]=AZU39RyRflTCP85NonOPbJDO-JCHUvLj_s7BEb7ewybdmhXUhTq0HQuAIn7FWkONBkyQSW6zkJ1v1r-SbckLYqjMNsh37uT3E5MvkLlgw1XPVAf9I7iaTjDdYi2r783FmAxkwAdmYC0pgvVNiUAHecbEBpZ6UCrgaHorZBbMRoWuG9v4UOndxllvne0HPnqfsfrP--UY2ORSeByN6sAwl6RuX49Q0GDogXXgkDT77w5r-g&__tn__=%2CO%2CP-R
With EFSA health claim regulations I think they will need to be careful what they can and cant say with regards to Fruitflow and Covid in Europe and i assume the same will apply in other countries that are regulated.
Hopefully the DSM big guns are working on this.
No FB post saying FF can help you “prepare for Covid”...., another secret being kept
W$
"Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding (19)."
NL, probably and it won't make any difference to cashflow.
Showing it here is just straw-clutching by some to make themselves feel better about the dire situation. Copy & paste doesn't work with PXS.
Big dilution coming up. Don't get spiked folks. It will be years before B/E.
It's as if the board can finally be arsed to provide news only because the AGM is coming up.
On the provexis site now great find Gixer . https://www.provexis.com/news/
Here is what Niamh O'Kennedy said about Fruitflow when asked will Fruitflow help to fight Covid-19 during the recent SmoFlo webinar
https://soundcloud.com/gix-er/covid-and-fruitflow/s-JyZwzfWUnRf
"Generally, only a limited number of food-derived compounds have been investigated for their antiplatelet effects clinically as of yet, whereby fish oils are synonymous. However, there has been some success in developing antiplatelet nutraceuticals. One such product is a water-soluble tomato-based nutraceutical given the trademarked name Fruitflow®. Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow"
Someone obviously has a bee in his bonnet about a certain poster, if it grinds you that much use the filter button, these derogatory childish comments put you in a bad light.
'course you do dear, 'course you do.
Sad
An excellent scholarly article which confirms what we all know, in that taking a product containing Fruitflow is very probably going to help someone fight off the effects of Covid-19 and have other beneficial effects as well.
But, no one doubts the excellence of fruitflow and this has been known for years but refuses to gain traction. The problem we have, IMO, is that DSM and Provexis have not made sufficient sale inroads to make enough money to turn a profit. Eleven years of spoof and groundless promises and we only have a third of a million quid gross income. How can that be justified or excused? Perhaps DSM are simply no good at marketing this product and the BOD are not proactive enough? I don't know, but something isn't right.
We are totally reliant on events in China IMO.
Gixer, by all means continue to discover excellent news about FF but to date, your research shows that the message is not getting through and I do wonder if it's too late.
Gixer... 'Do you think he reads the BB?'...no I don't think so...he was sent the information by a friendly source...but that source stopped sending right about the time the news dried up...
"Generally, only a limited number of food-derived compounds have been investigated for their antiplatelet effects clinically as of yet, whereby fish oils are synonymous. However, there has been some success in developing antiplatelet nutraceuticals. One such product is a water-soluble tomato-based nutraceutical given the trademarked name Fruitflow®. Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding"
https://www.frontiersin.org/articles/10.3389/fnut.2020.583080/full